DONATI, GIULIO
DONATI, GIULIO
Controversial relationship between the expression of the RB pathway components and RB protein phosphorylation in human breast cancer
2007 Montanaro L.; Vici M.; Donati G.; Ceccarelli C.; Santini D.; Treré D.; Derenzini M.
Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53- deficient and proficient human osteosarcoma cell lines.
2007 Montanaro L; Mazzini G; Barbieri S; Vici M; Nardi-Pantoli A; Govoni M; Donati G; Treré D; Derenzini M.
High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy.
2009 Treré D; Brighenti E; Donati G; Ceccarelli C; Santini D; Taffurelli M; Montanaro L; Derenzini M.
Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure.
2008 Derenzini M.; Donati G.; Mazzini G.; Montanaro L.; Vici M.; Ceccarelli C.; Santini D.; Taffurelli M.; Treré D.
Ribosome biogenesis and control of cell proliferation: p53 is not alone.
2012 Donati G; Montanaro L; Derenzini M.
Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation.
2011 Donati G; Brighenti E; Vici M; Mazzini G; Treré D; Montanaro L; Derenzini M.
The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells.
2011 Donati G; Bertoni S; Brighenti E; Vici M; Treré D; Volarevic S; Montanaro L; Derenzini M.
The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein.
2009 Derenzini M; Brighenti E; Donati G; Vici M; Ceccarelli C; Santini D; Taffurelli M; Montanaro L; Treré D.